This was evaluated by comparing tumor size (primary and metastatic peritoneal), histological and immunohistochemical analyses, quantification of stemness and activated PSC markers, determination of activities of caspase 3 and ALDH1A1, and assessment of cellular redox parameters and iron cellular uptake (ferroptosis markers). This evidence concerns the gene CASP3 and neoplasm.